Abstract
Objective
To report the efficacy of extracorporeal life support (ECLS) in acute carbamazepine poisoning with sustained refractory myocardial failure and a high degree of conductance disturbances.
Design and setting
Case report from the toxicological and medical intensive care unit in a university hospital.
Patient
A 26-year-old man with severe myocardial failure unresponsive to 1.7 μg kg−1 min−1 epinephrine and 1.9 μg kg−1 min−1 norepinephrine (SvO2, 17.8% and cardiac index, 0.8 l min−1 m−2) following a suicidal ingestion of 32 g slow-release carbamazepine.
Interventions
ECLS (Jostra-Maquet centrifugal pump (Rotaflow) connected to a hollow-fiber membrane oxygenator).
Measurements and results
ECLS device allowed inotropic drug weaning while maintaining end-organ function and supported the patient until myocardial recovery. The plasma carbamazepine level was 224 μmol/l on admission and peaked at 338 μmol/l 101 h after admission with a prolonged gastrointestinal absorption phase despite multiple doses of activated charcoal. The patient survived and was successfully explanted on day 6. An extensive and regressive thrombosis of the inferior vena cava was noted. Cardiac function totally recovered and at 2-year follow-up. There were no significant sequelae.
Conclusions
We report a case of life-threatening myocardial failure with conductance disturbances secondary to an acute carbamazepine poisoning, demonstrating the efficacy of ECLS to assist recovery.
References
Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D (2004) 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 22:335–404
Hojer J, Malmlund HO, Berg A (1993) Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone. J Toxicol Clin Toxicol 31:449–458
Faisy C, Guerot E, Diehl JL, Rezgui N, Labrousse J (2000) Carbamazepine-associated severe left ventricular dysfunction. J Toxicol Clin Toxicol 38:339–342
Cameron RJ, Hungerford P, Dawson AH (2002) Efficacy of charcoal hemoperfusion in massive poisoning. J Toxicol Clin Toxicol 40:507–512
Fisher RS, Cysyk B (1988) A fatal overdose of carbamazepine: case report and review of literature. J Toxicol Clin Toxicol 26:477–486
Denning DW, Matheson L, Bryson SM, Streete J, Berry DJ, Henry JA (1985) Death due to carbamazepine self-poisoning: remedies reviewed. Hum Toxicol 4:255–260
Seymour JF (1993) Carbamazepine overdose. Features of 33 cases. Drug Saf 8:81–88
No authors (1999) Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 37:731–751
Chetty M, Sarkar P, Aggarwal A, Sakhuja V (2003) Carbamazepine poisoning: treatment with haemodialysis. Nephrol Dial Transplant 18:220–221
Massetti M, Tasle M, Le Page O, Deredec R, Babatasi G, Buklas D, Thuaudet S, Charbonneau P, Hamon M, Grollier G, Gerard JL, Khayat A (2005) Back from irreversibility: extracorporeal life support for prolonged cardiac arrest. Ann Thorac Surg 79:178–183
Massetti M, Bruno P, Babatasi G, Neri E, Khayat A (2000) Cardiopulmonary bypass and severe drug intoxication. J Thorac Cardiovasc Surg 120:424–425
Brat R, Suk M, Barta J, Schichel T, Kozak D, Kucera T, Prusenovsky P, Urbanec R (2002) [Resuscitation of a patient with deep hypothermia using extracorporeal circulation]. Rozhl Chir 81:279–281
Apfelbaum JD, Caravati EM, Kerns WP 2nd, Bossart PJ, Larsen G (1995) Cardiovascular effects of carbamazepine toxicity. Ann Emerg Med 25:631–635
Spiller HA, Krenzelok EP, Cookson E (1990) Carbamazepine overdose: a prospective study of serum levels and toxicity. J Toxicol Clin Toxicol 28:445–458
Graudins A, Peden G, Dowsett RP (2002) Massive overdose with controlled-release carbamazepine resulting in delayed peak serum concentrations and life-threatening toxicity. Emerg Med (Fremantle) 14:89–94
Boehnert MT, Lovejoy FH Jr (1985) Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 313:474–479
Goldgran-Toledano D, Sideris G, Kevorkian JP (2002) Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 346:1591–1592
Monteban-Kooistra WE, van den Berg MP, Tulleken JE, Lightenberg JJM, Meertens JHJM, Zijlstra JG (2006) Brugada electrocardiographic pattern elicited by cyclic antidepressants overdose. Intensive Care Med 32:281–285
Banner W Jr (1996) Risks of extracorporeal membrane oxygenation: is there a role for use in the management of the acutely poisoned patient? J Toxicol Clin Toxicol 34:365–371
Purkayastha S, Bhangoo P, Athanasiou T, Casula R, Glenville B, Darzi AW, Henry JA (2006) Treatment of poisoning induced cardiac impairment using cardiopulmonary bypass: a review. Emerg Med J 23:246–250
Mégarbane B, Karyo S, Baud FJ (2004) The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning. Toxicol Rev 23:215–222
Deng JF, Shipe JR Jr, Rogol AD, Donowitz L, Spyker DA (1986) Carbamazepine toxicity: comparison of measurement of drug levels by HPLC and EMIT and model of carbamazepine kinetics. J Toxicol Clin Toxicol 24:281–294
Acknowledgements
The authors thank Dr. Rebeca Gracia, PharmD, DABAT, from the North Texas Poison Center, Dallas, Tex., USA, for her helpful review of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mégarbane, B., Leprince, P., Deye, N. et al. Extracorporeal life support in a case of acute carbamazepine poisoning with life-threatening refractory myocardial failure. Intensive Care Med 32, 1409–1413 (2006). https://doi.org/10.1007/s00134-006-0257-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-006-0257-8